Temc

425040 · KOSDAQ · ₩425040 · 티이엠씨

₩13,580▲ ₩440 (3.35%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +41.16%
Market cap
₩298B
Enterprise value
₩344B
P/E
16.3×
P/B
1.4×
Dividend yield
0.0%
ROE
8.6%
Net margin
6.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−55.2% from the high

₩6,300Today: ₩13,570 – ₩14,300₩30,300

Returns

  • 1W−10.5%
  • 1M+5.4%
  • 3M+75.2%
  • 6M−20.6%
  • YTD+77.5%
  • 1Y+41.2%
Volume today
413,926
0.4× the 20-day average
Traded today
₩5.8B
Listed shares
21,922,898
EPS (12 months)
₩835
Earnings yield 6.1%

Signals

31Quiet
  • BuzzQuietBuzz 31 of 100 (50 is a normal day for this stock).
  • MomentumFlat9% over the last month; the price is below its 20-day average.
  • News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Temc stock overview

Temc (티이엠씨, KRX: 425040) is listed on KOSDAQ, in the Chemicals sector. TEMC is a Korean company founded in 2015 and headquartered in Boeun County, Chungcheongbuk-do, that manufactures specialty gases used in semiconductor manufacturing. Its shares closed at ₩13,580 on Oct 27, 2026, up 3.35% on the day, giving it a market value of ₩298B.

Key facts

Market cap
₩298B
Sector
Chemicals
Latest price change
+3.35%
As of
Oct 27, 2026
Main business
TEMC is a Korean company founded in 2015 and headquartered in Boeun County, Chungcheongbuk-do, that manufactures specialty gases used in semiconductor manufacturing.

Quick answers about Temc

What does Temc do?
TEMC is a Korean company founded in 2015 and headquartered in Boeun County, Chungcheongbuk-do, that manufactures specialty gases used in semiconductor manufacturing. It holds in-house technology covering the full specialty gas production process, including gas synthesis, rare gas extraction and separation, and purification, mixing, and filling. Its customers include SK hynix, and its group also supplies semiconductor equipment, secondary battery equipment, and industrial gases.
What is the market cap of Temc?
The market capitalisation of Temc was ₩298B at the close on Oct 27, 2026.
Who are the largest shareholders of Temc?
According to the latest official filings, the largest reported holders are Yoo Won-yang (33.01%, as of Jun 11, 2026); POSCO Technology Investment (4.95%, as of Feb 21, 2025); National Pension Service (2.85%, as of Dec 31, 2025).
When is the next earnings report from Temc?
Korean companies rarely announce results dates in advance. Based on when Temc filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Temc?
Yes. The National Pension Service held 2.85% of Temc shares as of Dec 31, 2025.

Company profile

TEMC is a Korean company founded in 2015 and headquartered in Boeun County, Chungcheongbuk-do, that manufactures specialty gases used in semiconductor manufacturing. It holds in-house technology covering the full specialty gas production process, including gas synthesis, rare gas extraction and separation, and purification, mixing, and filling. Its customers include SK hynix, and its group also supplies semiconductor equipment, secondary battery equipment, and industrial gases.

Written by AI from the company's latest annual report.

Korean name
티이엠씨
Sector
Chemicals
CEO
유원양
Founded
Jan 2015
Listed
Jan 2023
Listed shares
21,922,898
Fiscal year ends
Month 12

Similar companies

Recent news

News · Maeil Business Newspaper·

[MK Signal] TEMC Shares Rise on Expectations for Competitiveness in Semiconductor Specialty Gases and Earnings Improvement… Up 18.11% Since MK Signal Recommendation

Predicted impact: Low· Actual: +9.3% vs sector, volume 0.7× normal (5 trading days)

Recommendation performance report; no company-specific news event.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Temc / 티이엠씨 / 425040 / KRX:425040

Source: KRX statistical information